KalVista Pharmaceuticals, Inc. has announced the granting of inducement stock options to five newly-hired employees as part of their compensation package. These options allow the purchase of a total of 23,000 shares of the company's common stock, effective from July 1, 2025. The exercise price for these options is set at the closing price of KalVista's stock on the grant date. The vesting schedule includes one-fourth of the options becoming available one year from the vesting commencement date, with the remaining options vesting in equal monthly installments over the following three years, contingent upon continued employment. Each option has a 10-year term and adheres to the guidelines of KalVista's Inducement Equity Incentive Plan. These grants were made under Nasdaq Listing Rule 5635(c)(4).
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.